Enfusion's receivables is $32M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Enfusion (ENFN) currently reports a receivables of $32M as of December 2024. That compares with $28M in the prior-year period — up 14.0% year over year. Use the charts on this page to explore Enfusion's receivables history and peer comparisons.
Enfusion's receivables increased from $28M to $32M — a 14.0% year-over-year increase (period ending December 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Enfusion reported $32M in receivables as of December 2024. That compares with $28M in the prior-year period — up 14.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current receivables of $32M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Enfusion, and consider following ENFN for alerts when major investors trade the stock.
Enfusion is classified in the Technology sector. On receivables, it currently shows $32M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Technology are usually more informative than comparing ENFN with unrelated industries.